Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | PLAU | P00749 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.30 |
| ▸ | FEN1 | P39748 | 2/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30135690 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TSHRTDP1ESR2PLAU | |
| SCHEMBL2548208 | 0.85 | ALDH1A1 (0.32) | ALDH1A1TSHRTDP1ESR2PLAU | |
| SCHEMBL28506719 | 0.82 | ALDH1A1 (0.35) | ALDH1A1TSHRTDP1ESR2PLAU | |
| SCHEMBL9960735 | 0.79 | GABRA1 (0.35) | ALDH1A1TSHRTDP1 | |
| SCHEMBL25258472 | 0.78 | FEN1 (0.40) | ALDH1A1TSHRTDP1ESR2ALOX5AP | |
| SCHEMBL18074251 | 0.78 | ALDH1A1 (0.32) | ALDH1A1TSHRTDP1ESR2PLAU | |
| SCHEMBL28882059 | 0.78 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ESR2PLAU | |
| SCHEMBL6677589 | 0.78 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1ESR2PLAU | |
| SCHEMBL28099521 | 0.77 | DPP4 (0.33) | — | |
| SCHEMBL3692332 | 0.77 | CA2 (0.40) | ALDH1A1TSHRTDP1CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2139838-B1 | A PROCESS FOR THE PREPARATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTOIC ACID | GRINDEKS JSC (LV) | 2012-03-28 | — | — | EP | claimed |
| US-20100160677-A1 | PROCESS FOR PREPARATION OF 6-[3-(1-ADMANTYL)-4-METHOXYPHENYL]-2-NAPHTOIC ACID. | JSC GRINDEKS (LV) | 2010-06-24 | — | — | US | claimed |
| US-20050026059-A1 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | TANAKA TAKAKAZU (JP) | 2005-02-03 | — | — | US | claimed |
| US-6818368-B2 | AN ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER INCLUDES CHARGE GENERATING AND CHARGE TRANSFER MATERIALS, CHARGE TRANSFER MATERIAL CONTAINS A TRIARYLAMINE COMPOUND FORMED FROM AN AMINE AND AN ARYLHALIDE WITH PHOSPHINE COMOUND CATALYST | CANON KABUSHIKI KAISHA (JP) | 2004-11-16 | — | — | US | claimed |
| US-20020048710-A1 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2002-04-25 | — | — | US | claimed |
| EP-3569606-B1 | METAL COMPLEXES OF CYCLOMETALLATED IMIDAZO (1,2-F)PHENANTHRIDINE AND DIIMIDAZO (1,2-A; 1', 2'-C)QUINAZOLINE LIGANDS AND ISOELECTRONIC AND BENZANNULATED ANALOGS THEREOF | UNIVERSAL DISPLAY CORP (US) | 2022-01-05 | — | — | EP | disclosed |
| US-10978649-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-04-13 | — | — | US | disclosed |
| US-10870715-B2 | Solid polyaluminoxane composition, olefin polymerization catalyst, olefin polymer production method and solid polyaluminoxane composition production method | MITSUI CHEMICALS, INC. (JP) | 2020-12-22 | — | — | US | disclosed |
| US-20200350504-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-05 | — | — | US | disclosed |
| US-10749121-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-08-18 | — | — | US | disclosed |
| EP-3569606-A1 | METAL COMPLEXES OF CYCLOMETALLATED IMIDAZO (1,2-F)PHENANTHRIDINE AND DIIMIDAZO (1,2-A; 1', 2'-C)QUINAZOLINE LIGANDS AND ISOELECTRONIC AND BENZANNULATED ANALOGS THEREOF | Universal Display Corporation (US) | 2019-11-20 | — | — | EP | disclosed |
| US-20190341563-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-11-07 | — | — | US | disclosed |
| WO-2003084972-A1 | RHODIUM COMPLEXES AND IRIDIUM COMPLEXES | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2003-10-16 | — | — | WO | disclosed |
| WO-2003080586-A1 | N-SULFONYLUREA APOPTOSIS PROMOTERS | ABBOTT LABORATORIES (US) | 2003-10-02 | — | — | WO | disclosed |
| WO-2003077918-A1 | DI-ARYL SUBSTITUTED TETRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 | MERCK & CO., INC. (US) | 2003-09-25 | — | — | WO | disclosed |
| US-20030166650-A1 | Cinnamide derivatives as KCNQ potassium channel modulators | BRISTOL-MYERS SQUIBB COMPANY | 2003-09-04 | — | — | US | disclosed |
| WO-2003062215-A1 | 4(HETERO-) ARYL SUBSTITUTED (THIA-/OXA-/PYRA) ZOLES FOR INHIBITION OF TIE-2 | KYLIX PHARMACEUTICALS B.V. (NL) | 2003-07-31 | — | — | WO | disclosed |
| WO-2003033476-A1 | PYRIMIDINONES AS MELANIN CONCENTRATING HORMONE RECEPTOR 1 | SMITHKLINE BEECHAM PLC (GB) | 2003-04-24 | — | — | WO | disclosed |
| WO-2002096858-A1 | CINNAMIDE DERIVATIVES AS KCNQ POTASSIUM CHANNEL MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-12-05 | — | — | WO | disclosed |
| US-20020048710-A1 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2002-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190341563-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LIG1, L1CAM, LIG3 | ALDH1A1 228/4885TSHR 4334/4885TDP1 1904/4885 |
| US-20030166650-A1 | Cinnamide derivatives as KCNQ potassium channel modulators | KCNH2, KCNH3, KCNQ1 | ALDH1A1 2914/4885TSHR 2004/4885TDP1 4537/4885 |
| US-10978649-B2 | Organic electroluminescent materials and devices | NR2C2, NR2E3, NCOA2 | ALDH1A1 2343/4885TSHR 2350/4885TDP1 4371/4885 |
| US-10749121-B2 | Organic electroluminescent materials and devices | LIG1, L1CAM, LIG3 | ALDH1A1 228/4885TSHR 4334/4885TDP1 1904/4885 |
| US-20100160677-A1 | PROCESS FOR PREPARATION OF 6-[3-(1-ADMANTYL)-4-METHOXYPHENYL]-2-NAPHTOIC ACID. | ME1, CD274, PDCD1LG2 | ALDH1A1 257/4885TSHR 1065/4885TDP1 2099/4885 |
| US-20200350504-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NR2C2, NR2E3, NCOA2 | ALDH1A1 2343/4885TSHR 2350/4885TDP1 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.